Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies

M Alenquer, F Ferreira, D Lousa, M Valério… - PLoS …, 2021 - journals.plos.org
Understanding SARS-CoV-2 evolution and host immunity is critical to control COVID-19
pandemics. At the core is an arms-race between SARS-CoV-2 antibody and angiotensin …

Antibody response against SARS-CoV-2 infection: Implications for diagnosis, treatment and vaccine development

A Mallano, A Ascione, M Flego - International Reviews of …, 2022 - Taylor & Francis
Many recent studies have reported the onset of a robust antibody response to SARS-CoV-2
infection and highlighted produced antibodies' specific qualitative and quantitative aspects …

Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals

E Fraley, C LeMaster, E Geanes, D Banerjee, S Khanal… - BMC medicine, 2021 - Springer
Background The global pandemic of coronavirus disease 2019 (COVID-19) is caused by
infection with the SARS-CoV-2 virus. Currently, there are three approved vaccines against …

[HTML][HTML] An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen

M Limonta-Fernández, G Chinea-Santiago… - New …, 2022 - Elsevier
Developing affordable and easily manufactured SARS-CoV-2 vaccines will be essential to
achieve worldwide vaccine coverage and long-term control of the COVID-19 pandemic …

The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2

J Guenthoer, ME Garrett, M Lilly, DM Depierreux… - PLoS …, 2024 - journals.plos.org
The SARS-CoV-2 virus responsible for the COVID-19 global pandemic has exhibited a
striking capacity for viral evolution that drives continued evasion from vaccine and infection …

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A …

S Karuna, SS Li, S Grant, SR Walsh, I Frank… - PLoS …, 2021 - journals.plos.org
Background People infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) experience a wide range of clinical manifestations, from asymptomatic and mild …

Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection

SA Lapp, VV Edara, A Lu, L Lai, L Hussaini… - PLoS …, 2021 - journals.plos.org
Background The effects of pre-existing endemic human coronavirus (HCoV) immunity on
SARS-CoV-2 serologic and clinical responses are incompletely understood. Objectives We …

[HTML][HTML] SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020

SF Lumley, DW Eyre, AL McNaughton… - …, 2020 - eurosurveillance.org
SARS-CoV-2 IgG screening of 1,000 antenatal serum samples in the Oxford area, United
Kingdom, between 14 April and 15 June 2020, yielded a 5.3% seroprevalence, mirroring …

A minimalist strategy towards temporarily defining protection for COVID-19

N Cimolai - SN Comprehensive Clinical Medicine, 2020 - Springer
Until either efficacious therapy or vaccination for COVID-19 is achieved, there will be a need
to regain world economic stability while yet controlling the pandemic with current …

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients

A Celikgil, AB Massimi, A Nakouzi, NG Herrera… - Plos one, 2023 - journals.plos.org
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target
multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins …